Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M215,727Revenue (TTM) $M50,992Net Margin (%)14.9Altman Z-Score2.5
Enterprise Value $M235,959EPS (TTM) $1.2Operating Margin %25.0Piotroski F-Score6
P/E(ttm)29.1Beneish M-Score-2.6Pre-tax Margin (%)18.5Higher ROA y-yN
Price/Book3.510-y EBITDA Growth Rate %2.6Quick Ratio1.2Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %0.6Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow15.9y-y EBITDA Growth Rate %-14.6ROA % (ttm)4.6Higher Current Ratio y-yN
Dividend Yield %3.3PEG47.0ROE % (ttm)11.6Less Shares Outstanding y-yY
Payout Ratio %93.0Shares Outstanding M6,065ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactup Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFERuane Cunniff 2015-12-31 Add$31.33 - $35.45
($33.17)
$ 35.577%Add 31.39%14,850
PFEBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Reduce-0.02%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -0.76%53,862,996
PFEDavid Dreman 2015-12-31 Sold Out -0.02%$31.33 - $35.45
($33.17)
$ 35.577%Sold Out0
PFEKen Fisher 2015-12-31 Add0.03%$31.33 - $35.45
($33.18)
$ 35.577%Add 1.28%32,334,417
PFEJohn Keeley 2015-12-31 Reduce-0.04%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -38.66%77,749
PFEPrem Watsa 2015-12-31 Reduce-0.07%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -10.64%210,000
PFECharles Brandes 2015-12-31 Reduce-0.1%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -3.82%5,639,537
PFEJohn Paulson 2015-12-31 Buy 0.13%$31.33 - $35.45
($33.17)
$ 35.577%New holding632,700
PFEVanguard Health Care Fund 2015-12-31 Reduce-0.25%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -29.31%8,872,226
PFET Rowe Price Equity Income Fund 2015-12-31 Add0.28%$31.33 - $35.45
($33.18)
$ 35.577%Add 15.28%14,525,000
PFEJoel Greenblatt 2015-12-31 Sold Out -0.32%$31.33 - $35.45
($33.17)
$ 35.577%Sold Out0
PFEFirst Eagle Investment 2015-12-31 Reduce-0.47%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -97.77%135,661
PFEKahn Brothers 2015-12-31 Reduce-0.59%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -6.05%1,569,873
PFENWQ Managers 2015-12-31 Reduce-1.16%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -54.84%1,967,718
PFEDodge & Cox 2015-12-31 Reduce-1.36%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -95.04%2,243,178
PFEDavid Tepper 2015-12-31 Buy 1.55%$31.33 - $35.45
($33.17)
$ 35.577%New holding2,412,250
PFELeon Cooperman 2015-12-31 Reduce-2.24%$31.33 - $35.45
($33.17)
$ 35.577%Reduce -73.18%1,295,600
PFEJohn Keeley 2015-09-30 Reduce$30.82 - $36.15
($33.8)
$ 35.575%Reduce -1.78%126,755
PFEDodge & Cox 2015-09-30 Add$30.82 - $36.15
($33.8)
$ 35.575%Add 0.07%45,266,436
PFERuane Cunniff 2015-09-30 Add$30.82 - $36.15
($33.8)
$ 35.575%Add 3.05%11,302
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.492.09view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.973.65view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.55.1view
YOUNG JOHN DGroup President 2016-05-10Sell41,700$33.535.01view
DAMELIO FRANK AExecutive Vice President 2016-05-10Sell192,000$33.664.6view
READ IAN CChairman & CEO 2016-05-09Sell275,000$33.84.17view
SUSMAN SALLYExecutive Vice President 2016-05-09Sell67,884$33.714.45view
HILL CHARLES HExecutive Vice President 2016-05-09Sell29,600$33.844.05view
MADDALUNA ANTHONY JExecutive Vice President 2016-05-09Sell8,950$33.754.33view
SUSMAN SALLYExecutive Vice President 2016-05-05Sell76,116$33.754.33view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Investors Cautious in Trading as Stocks End Day Lower Jun 22 2016 
    U.S. Market Indexes Gain as Investors Await UK Vote Jun 21 2016 
    Pfizer, Merck, Other Big Pharmas Likely to Acquire Marijuana-Based Drug Companies Jun 13 2016 
    U.S. Stocks Trade Flat at Start of Week May 09 2016 
    UnitedHealth’s Obamacare Changes to Affect Healthcare Sector Apr 27 2016 
    Does Biotech’s Recent Bounce Have Legs? Apr 22 2016 
    Pfizer-Allergen Merger Deal End Hurts Some Funds But Helps Many Apr 08 2016 
    Wilbur Ross Denounces Anti-Business 'Terrible Populist Sentiment' on CNBC Apr 07 2016 
    2 Major Mergers Come to End After Tough Stance From Regulators Apr 07 2016 
    Time To Buy Allergan Apr 06 2016 

    More From Other Websites
    The 4 Best biotech trades right now Jun 30 2016
    How Pfizer Continues Its Organic and Inorganic Growth Jun 30 2016
    Is Pfizer’s Valuation Low Compared to Peers? Jun 30 2016
    New partnership looks to improve lives of children living with HIV Jun 30 2016
    Pfizer's Rally Is Losing Momentum Jun 30 2016
    [$$] Who Will Acquire Medivation? Jun 30 2016
    This Biotech’s Stock Just Doubled and It’s Bad News for Sanofi Jun 29 2016
    How Pfizer, Merck May Feel Long-Term Pinch From Brexit Jun 29 2016
    How J&J Defied Brexit and Became the Year's Top Health Care Stock Jun 29 2016
    Pfizer: Why a Big Acquisition is Needed After Possible Split Jun 29 2016
    Pfizer's PCSK9 Inhibitor Tops Two Additional Phase III Studies Jun 29 2016
    Company News for June 29, 2016 Jun 29 2016
    Research Report Initiated on Select Major Drug Manufacturers Equities Jun 29 2016
    AstraZeneca’s cholesterol-drug gambit is the latest tactic from a company skilled at them Jun 29 2016
    AstraZeneca’s cholesterol-drug gambit is the latest tactic from a company skilled at them Jun 29 2016
    Why Pfizer Just Bet $350 Million On China (PFE) Jun 29 2016
    Allergan Seeks Smaller M&A for Growth After Pfizer Breakup Jun 29 2016
    Pfizer to Build $350M Biotech Center in China (PFE) Jun 28 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)